Effects of Wearable Vibratory Devices on Arm Function in Subacute Stroke Patients (NCT07641790) | Clinical Trial Compass
RecruitingNot Applicable
Effects of Wearable Vibratory Devices on Arm Function in Subacute Stroke Patients
Pakistan30 participantsStarted 2026-02-01
Plain-language summary
Hemiplegia, or paralysis of one side of the body, often results from stroke and severely limits arm function. Standard physiotherapy helps, but recovery is often slow. This study tests if adding a wearable vibratory device to standard therapy improves arm movement better than standard therapy alone. Thirty patients with subacute stroke (3-6 months) will be split into two groups. One group will receive usual physiotherapy, while the other will receive usual physiotherapy plus the vibratory device for 8 weeks. Doctors will measure changes in spasticity (muscle stiffness), motor function, and daily independence before and after treatment.
Who can participate
Age range
30 Years – 60 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Unilateral hemiplegia secondary to stroke
* Age between 30 and 60 years
* Subacute stage (3 to 6 months post-stroke)
* Fugl-Meyer Assessment (FMA) score between 20 and 50
* Able to follow simple verbal commands
Exclusion Criteria:
* Previous peripheral nerve injury or surgery affecting the upper limb
* Fixed contractures or bony fractures in the affected limb
* Complete sensory loss of the upper limb
* Co-existing neurological conditions (e.g., Parkinson's, MS, Dementia)
* Unstable cardiovascular conditions
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Change in Upper Limb Spasticity
Timeframe: Baseline (Week 0) and Post-intervention (Week 8)
2
Change in Upper Limb Motor Function
Timeframe: Baseline (Week 0) and Post-intervention (Week 8)